ESMA FIRDS · Issuer
LEI PY6ZZQWO2IZFZC3IOL08
4 bonds and equity instruments issued under LEI PY6ZZQWO2IZFZC3IOL08 as reported in ESMA FIRDS. Primary trading venue: MANL. Currencies: USD, EUR, GBP, BRL.
4 instruments · LEI: PY6ZZQWO2IZFZC3IOL08
Sample instruments
| ISIN | Name | Asset class | Currency | Venue |
|---|---|---|---|---|
| US046353AV09 | AZN 0.700 4/8/26 c ASTRAZENECA | Equity derivatives | USD | MANL |
| US046353AW81 | AZN 1 3/8 08/06/30 | Equity derivatives | USD | AURO |
| US046353AX64 | AZN 2 1/8 08/06/50 BOND | Equity derivatives | USD | BTFE |
| US046353AG32 | AZN 4 09/18/42 BOND | Equity derivatives | USD | FRAB |
| US046353AD01 | AZN 6.45 09/15/37 BOND | Equity derivatives | USD | FRAB |
| US046353AM00 | AZN 4 3/8 11/16/45 BOND | Equity derivatives | USD | FRAB |
| US046353AN82 | AZN 3 1/8 06/12/27 | Equity derivatives | USD | SSOB |
| US046353AT52 | AZN 4 01/17/29 BOND | Equity derivatives | USD | MUNB |
| US046353AU26 | AZN 4 3/8 08/17/48 BOND | Equity derivatives | USD | MUNB |
| US046353AZ13 | AZN 3 05/28/51 BOND | Equity derivatives | USD | BTFE |
| XS2593105393 | AZN 3 5/8 03/03/27 | Equity derivatives | EUR | BTFE |
| XS2593105476 | AZN 3 3/4 03/03/32 | Equity derivatives | EUR | BTFE |
| XS0330497149 | AZN 5 3/4 11/13/31 | Equity derivatives | GBP | FRAB |
| XS1411404426 | AZN 1 1/4 05/12/28 | Equity derivatives | EUR | FRAB |
| ARDEUT112489 | ASTRAZENECA ADR | Equity | USD | UBSI |
| XS2347663507 | AZN 0 3/8 06/03/29 | Equity derivatives | EUR | BTFE |
| BRA1ZNBDR003 | ASTRAZENECA PLC | Equity | BRL | UBSI |
| US0463531089 | AstraZeneca PLC | Equity | USD | TPIR |
| GB0009895292 | AstraZeneca PLC | Equity | USD | XSTO |
Issuer pages are generated for entities that appear as issuers of bonds or equity instruments in ESMA FIRDS. Individual instrument classifications reflect ESMA's own CFI-based asset class assignments and may differ from economic substance. All instruments are searchable via the ISIN search.
📋 Track EU financial regulation continuously
Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.
14-day free trial. No credit card required.